Ten management are keen to sell the business , that means there is no turnaround unless someone with deep pockets buys it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025